[ad_1] NEW YORK, Feb. 4, 2025 /PRNewswire/ — Pomerantz LLP announces that a class action lawsuit has been filed against Applied Therapeutics, Inc. (“Applied Therapeutics” or the “Company”) (NASDAQ: APLT). Such investors are advised to contact Danielle […]

[ad_1] NEW YORK, Jan. 21, 2025 /PRNewswire/ — Pomerantz LLP announces that a class action lawsuit has been filed against Joint Stock Company Kaspi.kz (“Kaspi.kz” or the “Company”) (NASDAQ: KSPI). Such investors are advised to contact Danielle Peyton […]

[ad_1] NEW YORK, Jan. 21, 2025 /PRNewswire/ — Pomerantz LLP announces that a class action lawsuit has been filed against BioAge Labs, Inc. (“BioAge” or the “Company”) (NASDAQ: BIOA). Such investors are advised to contact Danielle […]

[ad_1] NEW YORK, Jan. 21, 2025 /PRNewswire/ — Pomerantz LLP is investigating claims on behalf of investors of Edison International (“Edison” or the “Company”) (NYSE: EIX). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, […]

[ad_1] NEW YORK, Jan. 21, 2025 /PRNewswire/ — Pomerantz LLP is investigating claims on behalf of investors of JinkoSolar Holding Co., Ltd. (“JinkoSolar” or the “Company”) (NYSE: JKS). Such investors are advised to contact Danielle Peyton […]